JP2020518055A - 投与量捕捉のためのスマートフォンアプリおよび方法 - Google Patents
投与量捕捉のためのスマートフォンアプリおよび方法 Download PDFInfo
- Publication number
- JP2020518055A JP2020518055A JP2019556960A JP2019556960A JP2020518055A JP 2020518055 A JP2020518055 A JP 2020518055A JP 2019556960 A JP2019556960 A JP 2019556960A JP 2019556960 A JP2019556960 A JP 2019556960A JP 2020518055 A JP2020518055 A JP 2020518055A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- image
- dosage
- patient
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 229940079593 drug Drugs 0.000 claims abstract description 143
- 239000003814 drug Substances 0.000 claims abstract description 143
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 38
- 238000012377 drug delivery Methods 0.000 claims description 20
- 102000004877 Insulin Human genes 0.000 claims description 19
- 108090001061 Insulin Proteins 0.000 claims description 19
- 229940125396 insulin Drugs 0.000 claims description 19
- 239000006187 pill Substances 0.000 claims description 15
- 238000013500 data storage Methods 0.000 claims description 9
- 238000003384 imaging method Methods 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims 1
- 238000002483 medication Methods 0.000 abstract description 8
- 238000002716 delivery method Methods 0.000 abstract 1
- 238000004891 communication Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 108010092217 Long-Acting Insulin Proteins 0.000 description 2
- 102000016261 Long-Acting Insulin Human genes 0.000 description 2
- 229940100066 Long-acting insulin Drugs 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
- 239000002083 C09CA01 - Losartan Substances 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- 208000036647 Medication errors Diseases 0.000 description 1
- 108010026951 Short-Acting Insulin Proteins 0.000 description 1
- 229940123958 Short-acting insulin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 229960005370 atorvastatin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940038661 humalog Drugs 0.000 description 1
- WNRQPCUGRUFHED-DETKDSODSA-N humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 229940127560 insulin pen Drugs 0.000 description 1
- 229940060975 lantus Drugs 0.000 description 1
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 description 1
- 229960004773 losartan Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229940001450 onglyza Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- QGJUIPDUBHWZPV-SGTAVMJGSA-N saxagliptin Chemical compound C1C(C2)CC(C3)CC2(O)CC13[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-SGTAVMJGSA-N 0.000 description 1
- 108010033693 saxagliptin Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/50—Information retrieval; Database structures therefor; File system structures therefor of still image data
- G06F16/58—Retrieval characterised by using metadata, e.g. metadata not derived from the content or metadata generated manually
- G06F16/583—Retrieval characterised by using metadata, e.g. metadata not derived from the content or metadata generated manually using metadata automatically derived from the content
- G06F16/5838—Retrieval characterised by using metadata, e.g. metadata not derived from the content or metadata generated manually using metadata automatically derived from the content using colour
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/50—Information retrieval; Database structures therefor; File system structures therefor of still image data
- G06F16/58—Retrieval characterised by using metadata, e.g. metadata not derived from the content or metadata generated manually
- G06F16/583—Retrieval characterised by using metadata, e.g. metadata not derived from the content or metadata generated manually using metadata automatically derived from the content
- G06F16/5854—Retrieval characterised by using metadata, e.g. metadata not derived from the content or metadata generated manually using metadata automatically derived from the content using shape and object relationship
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
- G06F18/20—Analysing
- G06F18/22—Matching criteria, e.g. proximity measures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V10/00—Arrangements for image or video recognition or understanding
- G06V10/10—Image acquisition
- G06V10/17—Image acquisition using hand-held instruments
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V10/00—Arrangements for image or video recognition or understanding
- G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
- G06V10/74—Image or video pattern matching; Proximity measures in feature spaces
- G06V10/75—Organisation of the matching processes, e.g. simultaneous or sequential comparisons of image or video features; Coarse-fine approaches, e.g. multi-scale approaches; using context analysis; Selection of dictionaries
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/60—Type of objects
- G06V20/66—Trinkets, e.g. shirt buttons or jewellery items
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V30/00—Character recognition; Recognising digital ink; Document-oriented image-based pattern recognition
- G06V30/10—Character recognition
- G06V30/22—Character recognition characterised by the type of writing
- G06V30/224—Character recognition characterised by the type of writing of printed characters having additional code marks or containing code marks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
- A61M2005/3126—Specific display means related to dosing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6063—Optical identification systems
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Multimedia (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Data Mining & Analysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Databases & Information Systems (AREA)
- Library & Information Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Evolutionary Biology (AREA)
- Computing Systems (AREA)
- Software Systems (AREA)
- Bioinformatics & Computational Biology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims (15)
- 投与量情報を決定するためのポータブルデバイスであって、
薬剤または薬剤送達デバイスを撮像するための画像捕捉デバイスと、
画像捕捉デバイスによって捕捉された画像を記憶するためのメモリと、
プログラム命令を実行するように適合され、前記記憶された画像を分析し、および前記画像内に捕捉された薬剤のタイプおよび量を決定するように適合された、プログラマブルメモリおよびプロセッサと
を備えたことを特徴とするポータブルデバイス。 - 前記薬剤送達デバイスはインスリン送達ペンであり、前記画像はインスリン送達ペンのタイプを決定するために分析され、設定された投与量は前記インスリン送達ペン投与量ウィンドウから決定されることを特徴とする請求項1に記載のポータブルデバイス。
- 前記薬剤送達デバイスは注射器内にあり、前記画像は、前記注射器内の注射器プランジャ位置から前記投与量を決定するために分析されることを特徴とする請求項1に記載のポータブルデバイス。
- 前記薬剤は1つまたは複数の丸薬であり、前記画像は、前記丸薬画像を丸薬形状および色のデータベースと比較して、前記丸薬および薬剤濃度を識別するために分析されることを特徴とする請求項1に記載のポータブルデバイス。
- 所定の期間にわたる一連の投薬量に対応する一連の画像を捕捉するように構成され、前記捕捉された画像を分析し、薬剤投薬量を計算し、および各薬剤投薬量を記憶することを特徴とする請求項1に記載のポータブルデバイス。
- 前記所定の期間の間の前記薬剤の合計使用量を計算するように構成され、前記薬剤の前記合計使用量を前記患者のための処方された使用量と比較し、前記合計使用量が前記処方された使用量に少なくとも等しい、または前記処方された使用量未満であるとき、前記患者に通知を送ることを特徴とする請求項1に記載のポータブルデバイス。
- 薬剤送達手順を記録する方法であって、
ポータブル電子デバイスの画像捕捉デバイスを用いて、薬剤または薬剤送達デバイスの画像を捕捉するステップと、前記捕捉された画像を分析し、薬剤、投薬量、および送達情報を計算するステップと、前記薬剤、投薬量、および送達情報をデータ記憶媒体に記憶するステップと
を含むことを特徴とする方法。 - 所定の期間にわたる患者への連続した投薬量に対応する一連の画像を捕捉し、前記捕捉された画像を分析し、各薬剤投薬量を計算するステップと、前記投薬量情報を記憶するステップとをさらに含むことを特徴とする請求項7に記載の方法。
- 前記所定の期間にわたる前記薬剤の合計使用量を計算し、前記薬剤の前記合計使用量を、前記患者の貯蔵に対応する処方された使用量と比較するステップと、前記患者の前記薬剤の新たな貯蔵を提供するために、前記合計使用量が前記処方された使用量に少なくとも等しいとき、薬剤供給業者に通知を送るステップとをさらに含むことを特徴とする請求項8に記載の方法。
- 前記合計使用量が前記処方された使用量未満であるとき、前記患者に通知を送るステップをさらに含むことを特徴とする請求項9に記載の方法。
- 前記合計使用量が前記処方された使用量未満であるとき、前記医療関係者に通知を送るステップをさらに含むことを特徴とする請求項9に記載の方法。
- 前記薬剤または薬剤送達デバイスは、製造業者、薬剤のタイプ、および投薬量からなる群から選択された少なくとも1つに対応する表示を含み、前記表示の画像を捕捉し、前記捕捉された画像を分析し、前記製造業者、薬剤のタイプ、または投薬量を記録することを特徴とする請求項9に記載の方法。
- 前記薬剤送達デバイスはペンニードル送達デバイスであり、前記方法は、前記ペンニードル送達デバイス上に示された投薬量の画像を捕捉するステップと、前記投薬量を記録するステップとをさらに含むことを特徴とする請求項9に記載の方法。
- 前記送達デバイスはプランジャを有する注射器であり、前記方法は、前記注射器およびプランジャの画像を捕捉するステップと、前記画像を分析するステップと、前記患者に送達された投薬量に対応する前記プランジャの位置を計算するステップと、投薬量を記録するステップとを含むことを特徴とする請求項9に記載の方法。
- 前記薬剤は錠剤または丸薬であり、前記方法は、前記錠剤または丸薬の画像を捕捉するステップと、前記画像を分析して前記薬剤および投薬量を決定するステップと、前記薬剤および投薬量を記録するステップとを含むことを特徴とする請求項9に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762487997P | 2017-04-20 | 2017-04-20 | |
US62/487,997 | 2017-04-20 | ||
PCT/US2018/028322 WO2018195290A1 (en) | 2017-04-20 | 2018-04-19 | Smartphone app for dose capture and method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020518055A true JP2020518055A (ja) | 2020-06-18 |
JP7486952B2 JP7486952B2 (ja) | 2024-05-20 |
Family
ID=63856982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019556960A Active JP7486952B2 (ja) | 2017-04-20 | 2018-04-19 | 投与量捕捉のためのスマートフォンアプリおよび方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20200043589A1 (ja) |
EP (1) | EP3612976A4 (ja) |
JP (1) | JP7486952B2 (ja) |
CN (1) | CN110520864A (ja) |
CA (1) | CA3056446A1 (ja) |
WO (1) | WO2018195290A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11389596B2 (en) | 2018-01-12 | 2022-07-19 | Becton, Dickinson And Company | Smart vial adapter and method |
US11749393B2 (en) * | 2019-05-31 | 2023-09-05 | Becton, Dickinson And Company | Systems, apparatuses and methods for capturing images of medical condition management events and related equipment with smartphone and related app that processes images to reduce medical errors |
US11670412B2 (en) * | 2020-05-21 | 2023-06-06 | International Business Machines Corporation | Treatment adherence systems and processes |
WO2021260009A1 (en) * | 2020-06-25 | 2021-12-30 | Sanofi | Drug delivery device recognition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015197749A1 (en) * | 2014-06-27 | 2015-12-30 | Sanofi-Aventis Deutschland Gmbh | A monitoring system and method |
WO2016040949A1 (en) * | 2014-09-14 | 2016-03-17 | Becton, Dickinson And Company | System and method for capturing dose information |
US9317916B1 (en) * | 2013-04-12 | 2016-04-19 | Aic Innovations Group, Inc. | Apparatus and method for recognition of medication administration indicator |
WO2016062604A1 (en) * | 2014-10-21 | 2016-04-28 | Sanofi-Aventis Deutschland Gmbh | Recording dose data from drug injection devices using optical character recognition (ocr) |
JP2016126361A (ja) * | 2014-12-26 | 2016-07-11 | 株式会社日立ハイテクノロジーズ | 薬剤情報管理システム |
WO2016130815A1 (en) * | 2015-02-12 | 2016-08-18 | Kali Care, Inc. | Monitoring adherence to a medication regimen using a sensor |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002025568A2 (en) * | 2000-09-22 | 2002-03-28 | Sound Vision, Inc. | Pill identification and prescription management device, system and method |
US20140052468A1 (en) * | 2005-11-01 | 2014-02-20 | DoseCue, LLC | Medication Adherence System for and Method of Monitoring a Patient Medication Adherence and Facilitating Dose Reminders |
US8538775B2 (en) * | 2007-08-16 | 2013-09-17 | Qualcomm Incorporated | Mobile wireless medication management system |
US8448846B2 (en) * | 2007-11-18 | 2013-05-28 | Intel-Ge Care Innovations Llc | Medication recording device |
US20090177154A1 (en) | 2008-01-08 | 2009-07-09 | Michael Blomquist | Insulin pump with convenience features |
CN103502800A (zh) * | 2011-02-03 | 2014-01-08 | 思维斯洛格意大利股份公司 | 用于包装药物检查的系统和方法 |
WO2014006580A1 (en) * | 2012-07-05 | 2014-01-09 | Koninklijke Philips N.V. | Medication management device and method |
CN105120928B (zh) | 2013-04-22 | 2019-08-02 | 赛诺菲-安万特德国有限公司 | 与注射装置一起使用的辅助装置 |
US10383794B2 (en) * | 2013-10-23 | 2019-08-20 | Nexpil, Inc. | Medication compliance alert device |
WO2015116805A1 (en) * | 2014-01-29 | 2015-08-06 | Becton, Dickinson And Company | System and method for collection confirmation and sample tracking at the clinical point of use |
EP3021243A1 (en) * | 2014-11-11 | 2016-05-18 | Sanofi-Aventis Deutschland GmbH | Medicament dosage data collection |
US9345645B1 (en) * | 2015-04-07 | 2016-05-24 | Alex H. Chernyak | Bi-directional adaptive drug dispenser for managing divergence between pre-set regimen and actual performance |
US20170076060A1 (en) * | 2015-07-23 | 2017-03-16 | Cardinal Health Commercial Technologies, Llc | Medication dispensing device and methods |
US20170312457A1 (en) * | 2016-05-02 | 2017-11-02 | Nuance Designs Of Ct, Llc | Mobile imaging modality for medical devices |
US20180293357A1 (en) * | 2017-04-10 | 2018-10-11 | International Business Machines Corporation | Pill collection visual recognition for automatic compliance to prescriptions |
-
2018
- 2018-04-19 EP EP18788169.3A patent/EP3612976A4/en active Pending
- 2018-04-19 CA CA3056446A patent/CA3056446A1/en active Pending
- 2018-04-19 WO PCT/US2018/028322 patent/WO2018195290A1/en unknown
- 2018-04-19 US US16/498,584 patent/US20200043589A1/en active Pending
- 2018-04-19 JP JP2019556960A patent/JP7486952B2/ja active Active
- 2018-04-19 CN CN201880025800.5A patent/CN110520864A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9317916B1 (en) * | 2013-04-12 | 2016-04-19 | Aic Innovations Group, Inc. | Apparatus and method for recognition of medication administration indicator |
WO2015197749A1 (en) * | 2014-06-27 | 2015-12-30 | Sanofi-Aventis Deutschland Gmbh | A monitoring system and method |
WO2016040949A1 (en) * | 2014-09-14 | 2016-03-17 | Becton, Dickinson And Company | System and method for capturing dose information |
WO2016062604A1 (en) * | 2014-10-21 | 2016-04-28 | Sanofi-Aventis Deutschland Gmbh | Recording dose data from drug injection devices using optical character recognition (ocr) |
JP2016126361A (ja) * | 2014-12-26 | 2016-07-11 | 株式会社日立ハイテクノロジーズ | 薬剤情報管理システム |
WO2016130815A1 (en) * | 2015-02-12 | 2016-08-18 | Kali Care, Inc. | Monitoring adherence to a medication regimen using a sensor |
Also Published As
Publication number | Publication date |
---|---|
WO2018195290A1 (en) | 2018-10-25 |
CA3056446A1 (en) | 2018-10-25 |
US20200043589A1 (en) | 2020-02-06 |
CN110520864A (zh) | 2019-11-29 |
EP3612976A1 (en) | 2020-02-26 |
JP7486952B2 (ja) | 2024-05-20 |
EP3612976A4 (en) | 2021-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11200965B2 (en) | Apparatus and method for recognition of medication administration indicator | |
US11862033B2 (en) | Apparatus and method for recognition of patient activities | |
US11682488B2 (en) | Apparatus and method for recognition of patient activities when obtaining protocol adherence data | |
US11094408B2 (en) | Apparatus and method for recognition of inhaler actuation | |
JP7486952B2 (ja) | 投与量捕捉のためのスマートフォンアプリおよび方法 | |
ES2736954T3 (es) | Procedimiento de gestión y utilización mejoradas de datos de diabetes utilizando conectividad inalámbrica entre pacientes y proveedores de atención sanitaria, y repositorio de información de gestión de la diabetes | |
JP2005527009A (ja) | 医薬品の投与を監視するためのシステム及び方法 | |
US11017889B1 (en) | Methods and systems for graphical medicine display | |
US20190074077A1 (en) | Prescription management system and method | |
JP7284823B2 (ja) | 薬剤投与判定システムおよび薬剤投与判定プログラム | |
IL268796B2 (en) | Machine and system for drug distribution | |
US20240177625A1 (en) | Apparatus and Method for Recognition of Patient Activities | |
US10366462B1 (en) | Drug interaction review methods and systems | |
US20180082039A1 (en) | Prescription dispensing system and method of operation | |
Mohamed et al. | Medications errors prevention and its role in patient safety management | |
WO2024026240A1 (en) | System incentivizing and adjusting drug delivery | |
JP2021074399A (ja) | システム、準備装置、判定装置、及び、方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210129 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220225 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220308 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220415 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220726 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221125 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20221125 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20221205 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20221206 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20221216 |
|
C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20221220 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230411 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230822 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231219 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240508 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7486952 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |